PHAXIAM Therapeutics【PHXM】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

1.76

買値

1.74

売値

1.796

出来高

2,280

1.74 日の範囲 1.796

1.50 52 週間の範囲 4.23

時価総額

54.542M

前日終値

1.77

始値

1.796

時刻

1.76

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

15,662

発行済株式数

30,989,584

配当利回り

PER

-2.32

1 株当たり利益 (EPS)

-0.76

歳入

1.33M

純利益

-23.49M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.phaxiam.com

本社

Lyon, Rhone, Fra

設立

PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 1.77 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 1.50 € to 4.23 €.

PHAXIAM Therapeutics currently has 30,989,584 shares in issue. The market capitalisation of PHAXIAM Therapeutics is 54.85 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -2.32.

PHAXIAM Therapeutics annonce son calendrier financier 2025

Regulatory News: PHAXIAM Therapeutics (Euronext : PHXM – FR0011471135), société biopharmaceutique qui développe des traitements innovants pour les infections bactériennes sévères et résistantes...

PHAXIAM Therapeutics annonce des données cliniques actualisées issues de patients traités sous statut compassionnel en Europe

Des résultats cliniques prometteurs observés chez les 88 premiers patients évalués, confirmant l'innocuité et un bénéfice clinique important pour les patients Contrôle de l'infection à 3 mois...

PHAXIAM : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2024

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Regulatory News: PHAXIAM (Paris:PHXM) : Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 –...

PHAXIAM Therapeutics présente les données cliniques de l’étude pilote PhagoDAIR, dont les résultats confirment le design de l’étude clinique de Phase II GLORIA

Cette étude pilote non comparative1 incluant des patients présentant une infection sur prothèse ostéo-articulaire (PJI), a recruté 29 patients, dont 26 évaluables pour l’activité clinique sur...

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024 Article 223-16 du Règlement Général de...

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024 Article 223-16 of general regulation of French...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.068	-3.71991247265	1.828	1.828	1.682	12313	1.74613638	DE
4	0.02	1.14942528736	1.74	1.85	1.62	9742	1.72373565	DE
12	-0.04	-2.22222222222	1.8	2.145	1.5	15662	1.74266934	DE
26	-0.24	-12	2	2.145	1.5	10237	1.75505292	DE
52	-2.47	-58.3924349882	4.23	4.23	1.5	8925	2.1672059	DE
156	0.97	122.784810127	0.79	6	0.353	25346	1.19712935	DE
260	0.97	122.784810127	0.79	6	0.353	25346	1.19712935	DE

PHXM - Frequently Asked Questions (FAQ)

What is the current PHAXIAM Therapeutics share price?

The current share price of PHAXIAM Therapeutics is 1.76 €

How many PHAXIAM Therapeutics shares are in issue?

PHAXIAM Therapeutics has 30,989,584 shares in issue

What is the market cap of PHAXIAM Therapeutics?

The market capitalisation of PHAXIAM Therapeutics is EUR 54.85M

What is the 1 year trading range for PHAXIAM Therapeutics share price?

PHAXIAM Therapeutics has traded in the range of 1.50 € to 4.23 € during the past year

What is the PE ratio of PHAXIAM Therapeutics?

The price to earnings ratio of PHAXIAM Therapeutics is -2.32

What is the cash to sales ratio of PHAXIAM Therapeutics?

The cash to sales ratio of PHAXIAM Therapeutics is 41.12

What is the reporting currency for PHAXIAM Therapeutics?

PHAXIAM Therapeutics reports financial results in EUR

What is the latest annual turnover for PHAXIAM Therapeutics?

The latest annual turnover of PHAXIAM Therapeutics is EUR 1.33M

What is the latest annual profit for PHAXIAM Therapeutics?

The latest annual profit of PHAXIAM Therapeutics is EUR -23.49M

What is the registered address of PHAXIAM Therapeutics?

The registered address for PHAXIAM Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008

What is the PHAXIAM Therapeutics website address?

The website address for PHAXIAM Therapeutics is www.phaxiam.com

Which industry sector does PHAXIAM Therapeutics operate in?

PHAXIAM Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
HYPDSHipay Group DS	0.0024 € (200.00%)	1.83k
ALCYBCybergun	0.0002 € (100.00%)	16.61M
BNBSTonner Drones	0.0015 € (50.00%)	100
ALLPLLepermislibre SA	0.60 € (50.00%)	27.77k
ALVGVEOM Group	0.16 € (22.14%)	87.97k
ALTHETheraclion	0.23 € (-17.86%)	34.88k
MLPACPacte Novation	8.35 € (-14.80%)	3
ALALOAcheterLouerFR	0.0958 € (-12.91%)	121.44k
MLVIRVirtualware 2007 SA	7.40 € (-11.90%)	150
MLBONBonyf NV	15.90 € (-11.67%)	105
ATOAtos SE	0.0022 € (10.00%)	2.22B
BCPBanco Comercial Portugues SA	0.4802 € (0.00%)	49.83M
ALVERVergnet	0.0017 € (-5.56%)	18.84M
ALCYBCybergun	0.0002 € (100.00%)	16.61M
INGAING Groep NV	15.538 € (3.17%)	14.34M